Pnc Financial Services Group, Inc. Atossa Therapeutics, Inc. Transaction History

Pnc Financial Services Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.82 - $1.14 $4 - $6	6 New	6 $0
Q2 2022 Aug 12, 2022	SELL	$0.85 - $1.28 $212 - $320	-250 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.11 - $1.74 $277 - $435	250 New	250 $0
Q1 2020 May 08, 2020	SELL	$0.79 - $1.62 $52 - $106	-66 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$1.47 - $2.78 $97 - $183	66 New	66 $0

29M

39.8K

90.9K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $109M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.